Commission Implementing Regulation (EU) 2016/576 of 14 April 2016 amending Regulation (EU) No 37/2010 as regards the substance ‘rafoxanide’ (Text with EEA relevance)

• CELEX: Implementing Regulation (EU) 2016/576
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union .

It shall apply from 1 January 2016.

Schedules & Appendices

ANNEX

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘rafoxanide’ is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRL

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic Classification

‘Rafoxanide

Rafoxanide

Bovine

30 μg/kg

30 μg/kg

10 μg/kg

40 μg/kg

Muscle

Fat

Liver

Kidney

NO ENTRY

Antiparasitic agents/Agents against endoparasites’

Ovine

100 μg/kg

250 μg/kg

150 μg/kg

150 μg/kg

Muscle

Fat

Liver

Kidney

Bovine, ovine

10 μg/kg

Milk

Provisional MRL shall expire on 31 December 2017